HTS 3006 · Mexico · duty record
Pharmaceutical goods specified in note 4 to this chapter
Product description (continued): Goods in HTS heading 3006 from Mexico pay the general duty in the tariff schedule plus Section 301 10%. Across the 14 lines below the percentage total runs from 0% to 14.2%. Section 232 is added to the totals only where a plain percentage applies to the line and the country (conditional and country-deal rates are listed, not added), we found no IEEPA duty in force, and antidumping duties are not checked here.
Selected line / duty components
General schedule rate: Free
Pharmaceutical goods specified in note 4 to this chapter › Sterile surgical catgut, similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for surgical wound closure; sterile laminaria and sterile laminaria tents; sterile absorbable surgical or dental hemostatics; sterile surgical or dental adhesion barriers, whether or not absorbable
Click any code in the table below to show that line here.
Duty by line
14 tariff lines · MexicoPick your own 10-digit code from your classification or broker: the rate that applies to you is the one on your line. The last column is the percentage part only, on $10,000 of customs value.
14 lines shown
| Code | Product | General rate | Added duties | Total percentage | On $10,000 |
|---|---|---|---|---|---|
| Pharmaceutical goods specified in note 4 to this chapter › Sterile surgical catgut, similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for surgical wound closure; sterile laminaria and sterile laminaria tents; sterile absorbable surgical or dental hemostatics; sterile surgical or dental adhesion barriers, whether or not absorbable | Free | 10% Section 301 · adds | 10% | $1,000.00 | |
| Opacifying preparations for X-ray examinations; diagnostic reagents designed to be administered to the patient › Containing antigens or antisera | Free | none in our table | 0% | $0.00 | |
| Opacifying preparations for X-ray examinations; diagnostic reagents designed to be administered to the patient › Other | Free | none in our table | 0% | $0.00 | |
| Pharmaceutical goods specified in note 4 to this chapter › Dental cements and other dental fillings; bone reconstruction cements | Free | 10% Section 301 · adds | 10% | $1,000.00 | |
| Pharmaceutical goods specified in note 4 to this chapter › First-aid boxes and kits | Free | 10% Section 301 · adds | 10% | $1,000.00 | |
| Pharmaceutical goods specified in note 4 to this chapter › Chemical contraceptive preparations based on hormones, on other products of heading 2937 or on spermicides | Free | none in our table | 0% | $0.00 | |
| Pharmaceutical goods specified in note 4 to this chapter › Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | 5% | none in our table | 5% | $500.00 | |
| Pharmaceutical goods specified in note 4 to this chapter › Appliances identifiable for ostomy use | 4.2% | 10% Section 301 · adds | 14.2% | $1,420.00 | |
| Pharmaceutical goods specified in note 4 to this chapter › Waste pharmaceuticals | Free | none in our table | 0% | $0.00 | |
| Placebos and blinded (or double-blinded) clinical trial kits for a recognized clinical trial, put up in measured doses › Packaged with medicinal preparations | Free | none in our table | 0% | $0.00 | |
| Placebos and blinded (or double-blinded) clinical trial kits for a recognized clinical trial, put up in measured doses › Containing over 10 percent by dry weight of sugar | $0.4/kg + 10.4% | none in our table | 10.4%plus $0.40 per kg | $1,040.00 + per-unit part | |
| Placebos and blinded (or double-blinded) clinical trial kits for a recognized clinical trial, put up in measured doses › Containing ingredients having nutritional value, in which starch or other foodstuff predominates by weight | 6.4% | none in our table | 6.4% | $640.00 | |
| Placebos and blinded (or double-blinded) clinical trial kits for a recognized clinical trial, put up in measured doses › In liquid form for oral intake | $0.002/liter | none in our table | 0%plus $0.00 per liter | $0.00 + per-unit part | |
| Placebos and blinded (or double-blinded) clinical trial kits for a recognized clinical trial, put up in measured doses › Placebos and clinical trial kits containing other chemicals other than medicaments | 5% | none in our table | 5% | $500.00 |
What is and is not counted
Rules applied to Mexico
- 10% Section 301 since 2026-07-24 — source (9903.05.20-9903.05.84 (headings by country))
2026 Section 301 action (91 FR 47318, U.S. note 52): 10% on top of the general rate, from 24 July 2026, for the countries named in headings 9903.05.22, 9903.05.26, 9903.05.28, 9903.05.29, 9903.05.35, 9903.05.37, 9903.05.40, 9903.05.42, 9903.05.44, 9903.05.45, 9903.05.50, 9903.05.54, 9903.05.55, 9903.05.62, 9903.05.72, 9903.05.78, 9903.05.81. Not charged on goods the note exempts (agricultural list, civil aircraft, pharmaceuticals, and every product on a Section 232 list); other exemptions (Canada and Mexico goods that enter free under USMCA, CAFTA-DR textiles, country-specific lists) are not modelled.
Section 232: what the proclamations say about chapter 30
These are summaries of the official proclamations. Where the tariff schedule notes give a plain percentage for your line and country, it is already in the duty above (see the layer list). Rates that depend on a fact only you know (the share of metal by weight, U.S.-made metal, a country deal, a USMCA claim) are listed but not added. Check your own line against the official list or ask your broker.
Pharmaceuticals and pharmaceutical ingredients in force
- Proclamation 11020 (2026-04-09). USITC HTS 2026HTSRev23, U.S. note 40 and headings 9903.04.60 to 9903.04.70. Patented pharmaceutical articles: total rate 100% (heading 9903.04.60); 15% total for products of Japan, the EU, South Korea, Switzerland and Liechtenstein (9903.04.62); the United Kingdom +0% (9903.04.63); +20% for companies with an approved onshoring plan (9903.04.64). Generic products, orphan drugs, nuclear medicines, plasma therapies, fertility treatments, cell and gene therapies, clinical-trial products and several other groups pay nothing extra (9903.04.61, .65 to .70).
- Product list (added 2026-11-21): 149 code prefixes parsed from note 40(c) (chapters 29 and 30). Whether the duty applies depends on patent status and the importer, which the product code cannot show, so every row is listed and none is added to totals. The pack holds neither chapter 29 nor chapter 30, so no tariff line of the site resolves to these rows yet.
Read from the proclamation on 2026-11-21. Sources: Proclamation 11020 (Federal Register document 2026-06956)
Pending and recent notices for this heading
- No change CSMS # 70435180 - Updated Guidance #5: Implementation of Jones Act Waiver issued to the Department of War, dated March 17, 20262026-11-13
- No change Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Comment Request; Section 232 National Security Adjustments to Imports of Specialty Pharmaceuticals and Associated Ingredients2026-11-06 · pending